These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 10325923)

  • 1. Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.
    Egermayer P; Town GI; Peacock AJ
    Thorax; 1999 Feb; 54(2):161-8. PubMed ID: 10325923
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of humoral mediators in adult respiratory distress syndrome.
    Hechtman HB; Valeri CR; Shepro D
    Chest; 1984 Oct; 86(4):623-7. PubMed ID: 6383742
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical application of serotonin antagonists in the treatment of hypertension].
    Deguchi F; Saito T; Inagaki Y
    Nihon Rinsho; 1989 Sep; 47(9):2058-63. PubMed ID: 2593279
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin.
    Herve P; Drouet L; Dosquet C; Launay JM; Rain B; Simonneau G; Caen J; Duroux P
    Am J Med; 1990 Jul; 89(1):117-20. PubMed ID: 2368783
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of serotonin inhibition in air embolism in dogs.
    Vincent JL; Goldstein J; Domb M; Lignan H
    Eur Surg Res; 1988; 20(3):175-80. PubMed ID: 3402512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of ketanserin either alone or with oxygen in COPD patients with secondary pulmonary hypertension.
    Domenighetti G; Leuenberger P; Feihl F
    Monaldi Arch Chest Dis; 1997 Oct; 52(5):429-33. PubMed ID: 9510660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoid crisis during transesophageal echocardiography.
    Janssen M; Salm EF; Breburda CS; van Woerkens LJ; de Herder WW; v/d Zwaan C; Roelandt JR
    Intensive Care Med; 2000 Feb; 26(2):254. PubMed ID: 10784323
    [No Abstract]   [Full Text] [Related]  

  • 8. Serotonin antagonists.
    Anthony M
    Aust N Z J Med; 1984 Dec; 14(6):888-95. PubMed ID: 6398056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin: a selective serotonin antagonist.
    Lancet; 1982 Oct; 2(8303):859. PubMed ID: 6126719
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of serotonin in the regulation of the circulatory system].
    Buczko W
    Pol Tyg Lek; 1985 Apr; 40(16):469-72. PubMed ID: 3160011
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoid syndrome and serotonin: therapeutic effects of ketanserin.
    Robertson JI
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():53-8. PubMed ID: 2285651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serotonin and its physiological and pathophysiological roles. Ketanserin].
    Metelitsa TV
    Kardiologiia; 1989 Sep; 29(9):120-5. PubMed ID: 2687555
    [No Abstract]   [Full Text] [Related]  

  • 13. The relevance of serotonin antagonism in the treatment of hypertension.
    Doyle AE
    Drugs; 1988; 36 Suppl 1():67-73. PubMed ID: 3240730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic use of ketanserin in a patient with carcinoid syndrome.
    Fischler M; Dentan M; Westerman MN; Vourc'h G; Freitag B
    Br J Anaesth; 1983 Sep; 55(9):920. PubMed ID: 6615683
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketanserin in the treatment of protamine-induced pulmonary hypertension.
    van der Starre PJ; Solinas C
    Tex Heart Inst J; 1996; 23(4):301-4. PubMed ID: 8969033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serotonin and cardiovascular diseases. Pathophysiology and significance of serotonin antagonists].
    Lüscher TF; Tanner FC; Bühler FR
    Dtsch Med Wochenschr; 1992 Apr; 117(18):710-9. PubMed ID: 1572260
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats.
    Eddahibi S; Raffestin B; Pham I; Launay JM; Aegerter P; Sitbon M; Adnot S
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1173-81. PubMed ID: 9087590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic type-2 (5-HT2) antagonists: a novel class of cardiovascular drugs.
    Robertson JI
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S48-53. PubMed ID: 1717773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and the vascular system. Role in health and disease, and implications for therapy.
    Houston DS; Vanhoutte PM
    Drugs; 1986 Feb; 31(2):149-63. PubMed ID: 3512233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary manifestations of the antiphospholipid antibody syndrome.
    Ford HJ; Roubey RA
    Clin Chest Med; 2010 Sep; 31(3):537-45. PubMed ID: 20692545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.